E. Spence

928 total citations
20 papers, 646 citations indexed

About

E. Spence is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, E. Spence has authored 20 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hepatology, 7 papers in Epidemiology and 5 papers in Rheumatology. Recurrent topics in E. Spence's work include Hepatitis C virus research (8 papers), Liver Disease Diagnosis and Treatment (6 papers) and Hepatitis B Virus Studies (4 papers). E. Spence is often cited by papers focused on Hepatitis C virus research (8 papers), Liver Disease Diagnosis and Treatment (6 papers) and Hepatitis B Virus Studies (4 papers). E. Spence collaborates with scholars based in United Kingdom, United States and Austria. E. Spence's co-authors include Peter R. Mills, Robin Russell, B J Danesh, A J Morris, Jennifer M. Lang, M. Allison, Ray Fox, E. A. B. McCruden, Karin A. Oien and R. N. M. MacSween and has published in prestigious journals such as Gut, Journal of Hepatology and Journal of the American Academy of Dermatology.

In The Last Decade

E. Spence

18 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Spence United Kingdom 11 232 196 191 177 152 20 646
W Luman Singapore 17 147 0.6× 191 1.0× 36 0.2× 39 0.2× 33 0.2× 32 911
Nicola Impagliazzo Italy 7 37 0.2× 88 0.4× 50 0.3× 87 0.5× 11 0.1× 8 324
Laura Merras‐Salmio Finland 18 352 1.5× 117 0.6× 29 0.2× 87 0.5× 19 0.1× 52 768
Chiara Zanfi Italy 18 296 1.3× 97 0.5× 183 1.0× 26 0.1× 8 0.1× 46 755
Serena Arrigo Italy 14 79 0.3× 104 0.5× 18 0.1× 18 0.1× 41 0.3× 70 585
Rabin Persad Canada 15 134 0.6× 113 0.6× 15 0.1× 46 0.3× 30 0.2× 28 689
R.G. Buick United Kingdom 17 260 1.1× 41 0.2× 29 0.2× 32 0.2× 39 0.3× 33 829
Catherine Baujard France 14 25 0.1× 145 0.7× 295 1.5× 17 0.1× 11 0.1× 27 705
Fabio Panetta Italy 12 140 0.6× 111 0.6× 14 0.1× 59 0.3× 25 0.2× 25 474
Kapil Kapur United Kingdom 13 78 0.3× 88 0.4× 9 0.0× 66 0.4× 77 0.5× 29 631

Countries citing papers authored by E. Spence

Since Specialization
Citations

This map shows the geographic impact of E. Spence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Spence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Spence more than expected).

Fields of papers citing papers by E. Spence

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Spence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Spence. The network helps show where E. Spence may publish in the future.

Co-authorship network of co-authors of E. Spence

This figure shows the co-authorship network connecting the top 25 collaborators of E. Spence. A scholar is included among the top collaborators of E. Spence based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Spence. E. Spence is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spence, E., et al.. (2013). 859 POSSIBLE TOXIC HEPATITIS DUE TO POLYETHYLENE GLYCOL DURING TREATMENT FOR CHRONIC HEPATITIS C. Journal of Hepatology. 58. S352–S352.
2.
Spence, E., Ramesh Chelvarajah, & Colin Shieff. (2012). Haemangiopericytoma with no dural attachment. BMJ Case Reports. 2012. bcr1120115179–bcr1120115179. 2 indexed citations
3.
Hutchinson, Sharon, S. Cameron, Ellen Zambo Anderson, et al.. (2011). Identifying former injecting drug users infected with hepatitis C: an evaluation of a general practice-based case-finding intervention. Journal of Public Health. 34(1). 14–23. 40 indexed citations
4.
Shajahan, Polash, et al.. (2010). Comparison of the effectiveness of depot antipsychotics in routine clinical practice. The Psychiatrist. 34(7). 273–279. 8 indexed citations
5.
Hutchinson, Sharon, et al.. (2009). Evaluation of a General Practice Based Hepatitis C Virus Screening Intervention. Scottish Medical Journal. 54(3). 3–7. 29 indexed citations
6.
Elliott, John F., Cory Smith, Peter R. Mills, et al.. (2007). Translation efficiencies of the 5′‐untranslated region of genotypes 1a and 3a in hepatitis C infected patients. Journal of Medical Virology. 79(3). 259–269. 4 indexed citations
7.
Williams, Gillian, et al.. (2005). Retinal toxicity during pegylatedα‐interferon therapy for chronic hepatitis C: a multifocal electroretinogram investigation. Alimentary Pharmacology & Therapeutics. 21(6). 723–732. 18 indexed citations
8.
Forrest, Ewan, Douglas Thorburn, E. Spence, et al.. (2005). Polymorphisms of the renin–angiotensin system and the severity of fibrosis in chronic hepatitis C virus infection. Journal of Viral Hepatitis. 12(5). 519–524. 18 indexed citations
9.
Spence, E., et al.. (2005). Kinetics of Polyurethane Formation in Polymerization Reactions Using the Organometallic Diol (η5-C5H4CH2CH2OH)2Mo2(CO)6. Journal of Inorganic and Organometallic Polymers and Materials. 15(2). 221–230. 3 indexed citations
10.
Williford, William O., Joseph F. Collins, Gail Kirk, et al.. (2003). The role of the data coordinating center in the DIG trial. Controlled Clinical Trials. 24(6). S277–S288. 6 indexed citations
11.
Thorburn, Douglas, E. Spence, Karin A. Oien, et al.. (2002). The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C. Gut. 50(2). 248–252. 109 indexed citations
12.
Muir, Margaret, et al.. (2001). Oral health of patients with hepatitis C virus infection: a pilot study. Oral Diseases. 7(5). 271–275. 47 indexed citations
13.
Gupta, Girish, et al.. (2000). Capillaritis associated with interferon-alfa treatment of chronic hepatitis C infection. Journal of the American Academy of Dermatology. 43(5). 937–938. 8 indexed citations
14.
Gupta, Girish, et al.. (2000). Capillaritis associated with interferon-alfa treatment of chronic hepatitis C infection. Journal of the American Academy of Dermatology. 43(5). 937–938. 1 indexed citations
15.
Thorburn, Douglas, George Bird, E. Spence, R N MacSween, & Peter R. Mills. (1996). α-Glutathione S-transferase levels in chronic hepatitis C infection and the effect of α-interferon therapy. Clinica Chimica Acta. 253(1-2). 171–180. 10 indexed citations
16.
Bird, George, E. Spence, Kenneth J. Hillan, et al.. (1995). Genotypic variation, clinical and histological characteristics of chronic hepatitis C detected at blood donor screening. Journal of Viral Hepatitis. 2(5). 261–265. 4 indexed citations
17.
Roy, Koyel, Jeremy Bagg, George Bird, et al.. (1995). Serological and salivary markers compared with biochemical markers for monitoring interferon treatment for hepatitis C virus infection. Journal of Medical Virology. 47(4). 429–434. 17 indexed citations
18.
Allison, M., Jennifer M. Lang, E. Spence, et al.. (1992). Randomised comparison of percutaneous endoscopic gastrostomy and nasogastric tube feeding in patients with persisting neurological dysphagia.. BMJ. 304(6839). 1406–1409. 297 indexed citations
19.
Craft, Alan, Gordon Dale, Andrew C. McGill, John Seviour, & E. Spence. (1989). Biochemical screening for neuroblastoma in infants: A feasibility study. Medical and Pediatric Oncology. 17(5-6). 373–378. 13 indexed citations
20.
Pitcher, C. S. & E. Spence. (1963). Fatal Marrow Aplasia Complicating Infectious Hepatitis. BMJ. 1(5324). 171–172. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W Luman Breakdown of academic impact, for papers by Nicola Impagliazzo Breakdown of academic impact, for papers by Laura Merras‐Salmio Breakdown of academic impact, for papers by Chiara Zanfi Breakdown of academic impact, for papers by Serena Arrigo Breakdown of academic impact, for papers by Rabin Persad Breakdown of academic impact, for papers by R.G. Buick Breakdown of academic impact, for papers by Catherine Baujard Breakdown of academic impact, for papers by Fabio Panetta Breakdown of academic impact, for papers by Kapil Kapur
Rankless by CCL
2026